DGX vs DOCS · P/E 22, rev $9.87B vs P/E 21, rev $570.4M
Quest Diagnostics Incorporated (DGX) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the DGX and DOCS stock pages for the full models.
Not investment advice.